pI: 5.8849 |
Length (AA): 515 |
MW (Da): 58001 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
20 | 581 | 1omw (A) | 96 | 654 | 19.00 | 0 | 1 | 0.91 | 0.7 |
23 | 580 | 1omw (A) | 115 | 667 | 20.00 | 0 | 1 | 1.05 | 0.39 |
104 | 406 | 2bfx (A) | 87 | 354 | 32.00 | 0 | 1 | 0.89 | -0.99 |
4 | 515 | 3pvu (A) | 159 | 666 | 20.00 | 0 | 1 | 1.07417 | 0.67 |
30 | 261 | 2ivs (B) | 718 | 951 | 30.00 | 0.00000032 | 1 | 0.567785 | 0.15 |
34 | 338 | 5lvo (A) | 80 | 356 | 38.00 | 0 | 1 | 0.974333 | -0.4 |
360 | 514 | 4uos (A) | 19 | 172 | 8.00 | 0 | 0 | 0.489471 | -1.75 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 merozoite, ME49 Oocyst. | Gregory Hehl AB Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Ortholog group members (OG5_136837)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_I000170 | protein kinase domain containing protein |
Cryptosporidium hominis | Chro.10297 | hypothetical protein |
Cryptosporidium parvum | cgd1_2630 | Ser/Thr protein kinase |
Dictyostelium discoideum | DDB_G0281471 | PDK1 family protein kinase |
Neospora caninum | NCLIV_037990 | AGC kinase, putative |
Plasmodium berghei | PBANKA_0926400 | serine/threonine protein kinase, putative |
Plasmodium falciparum | PF3D7_1121900 | serine/threonine protein kinase, putative |
Plasmodium knowlesi | PKNH_0919600 | protein kinase, putative |
Plasmodium vivax | PVX_091715 | 3-phosphoinositide dependent protein kinase-1, putative |
Plasmodium yoelii | PY06967 | serine/threonine kinase 13-related |
Toxoplasma gondii | TGME49_268210 | AGC kinase |
Theileria parva | TP03_0842 | protein kinase, putative |
Theileria parva | TP03_0843 | hypothetical protein |
Theileria parva | TP03_0844 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_268210 this record | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | cAMP-dependent protein kinase alpha-catalytic subunit | 351 aa | 29.6% | 291 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-A | 361 aa | 29.7% | 310 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 22.3% | 264 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 24.6% | 179 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 23.5% | 264 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 21.7% | 267 aa | Compounds | References |
Bos taurus | cAMP-dependent protein kinase alpha-catalytic subunit | 351 aa | 29.2% | 291 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-B | 368 aa | 30.1% | 326 aa | Compounds | References |
Oryctolagus cuniculus | cAMP-dependent protein kinase alpha-catalytic subunit | 351 aa | 27.8% | 291 aa | Compounds | References |
52 literature references were collected for this gene.